Acute Ischemic Stroke (Large Vessel Occlusion)

Comprehensive Clinical Guide: Acute Ischemic Stroke (Large Vessel Occlusion)

1. Introduction & Overview

Acute Ischemic Stroke (AIS) secondary to Large Vessel Occlusion (LVO) represents a critical medical emergency characterized by the sudden cessation of blood flow to a major intracranial artery. Unlike minor strokes resulting from small-vessel disease, LVO involves the occlusion of proximal vessels—typically the internal carotid artery (ICA), the M1 or M2 segments of the middle cerebral artery (MCA), the basilar artery, or the vertebral arteries.

LVO-related strokes are responsible for a disproportionate share of stroke-related morbidity and mortality. Because these vessels supply extensive territories of the brain, the resulting ischemia can lead to rapid, catastrophic neurological deficit. The clinical mantra "Time is Brain" is most pertinent here; for every minute of large vessel occlusion, approximately 1.9 million neurons, 14 billion synapses, and 7.5 miles of myelinated fibers are lost.

2. Etiology and Pathophysiology

Etiology

The pathophysiology of LVO is primarily rooted in thromboembolic events, though the source of the embolus varies:
* Cardioembolism: The most common cause, frequently associated with Atrial Fibrillation (AFib), mural thrombi post-myocardial infarction, or valvular heart disease.
* Large Artery Atherosclerosis: In-situ thrombosis resulting from plaque rupture in the carotid or intracranial arteries.
* Arterial Dissection: Common in younger patients, often related to trauma or connective tissue disorders.
* Cryptogenic: Approximately 25–30% of cases remain unexplained despite thorough workup (ESUS - Embolic Stroke of Undetermined Source).

Pathophysiology

When an LVO occurs, the brain tissue undergoes a predictable cascade of injury:
1. Core Infarction: The central zone where blood flow drops below 10–12 mL/100g/min. This tissue suffers rapid ATP depletion, failure of ion pumps, and cytotoxic edema, resulting in irreversible cell death within minutes.
2. Ischemic Penumbra: The surrounding area of hypoperfused tissue where blood flow is reduced but collateral circulation maintains cellular viability. This tissue is electrically silent but structurally intact.
3. The Goal of Intervention: Mechanical thrombectomy and thrombolysis aim to salvage the penumbra before it transitions into the irreversible infarct core.

3. Clinical Presentation and Staging

Standard Presentation

Patients with LVO often present with severe, sudden-onset symptoms. The NIH Stroke Scale (NIHSS) is the gold standard for quantifying the deficit.
* MCA Occlusion: Contralateral hemiparesis, hemianesthesia, conjugate eye deviation toward the lesion, and global aphasia (if dominant hemisphere).
* Basilar Artery Occlusion: "Locked-in" syndrome, cranial nerve palsies, altered consciousness, and quadriparesis.
* ICA Occlusion: Massive hemisphere involvement, often resulting in malignant edema and rapid decline in consciousness.

Clinical Grading (NIHSS Scale)

LVO is highly suspected in patients with an NIHSS score ≥ 6.

4. Diagnostic Workup

Rapid diagnosis is mandatory to qualify patients for endovascular therapy (EVT).

1. Non-Contrast CT (NCCT): Primary goal is to rule out intracranial hemorrhage (ICH). The ASPECTS score is utilized to quantify early ischemic changes on CT (a score of <6 indicates a large core infarct).
2. CT Angiography (CTA): The definitive tool for identifying the LVO. It visualizes the intracranial vasculature from the aortic arch to the circle of Willis.
3. CT Perfusion (CTP): Advanced imaging used to differentiate between the infarct core and the salvageable penumbra. This is critical for patients presenting in the "extended window" (6–24 hours post-onset).
4. MRI (DWI/FLAIR): Highly sensitive for acute ischemia but often bypassed in hyperacute settings due to time constraints.

5. Management and Therapeutic Interventions

Standard of Care

• Intravenous Thrombolysis (IVT): Alteplase or Tenecteplase, if administered within 4.5 hours of symptom onset.
• Mechanical Thrombectomy (MT): The standard of care for LVO. Using stent retrievers or aspiration catheters, the neuro-interventionalist physically removes the clot. MT is recommended up to 24 hours post-onset in select patients (DAWN/DEFUSE-3 criteria).

Risks and Contraindications

• IVT Contraindications: Recent surgery, active bleeding, anticoagulation with elevated INR, or uncontrolled severe hypertension (>185/110 mmHg).
• Procedural Risks (MT): Vessel perforation, distal embolization to previously unaffected territories, arterial dissection, and contrast-induced nephropathy.

6. Long-Term Prognosis and Rehabilitation

Post-acute care focuses on preventing secondary stroke and maximizing functional recovery.
* Secondary Prevention: Initiation of antiplatelet therapy, statin therapy for plaque stabilization, and anticoagulation if AFib is identified.
* Rehabilitation: Essential for neuroplasticity. Multidisciplinary care involving Physical Therapy (PT), Occupational Therapy (OT), and Speech-Language Pathology (SLP).
* Prognostic Indicators: Age, baseline NIHSS, collateral circulation quality, and the time-to-recanalization (TICI score).

7. Massive FAQ Section

1. What is the difference between a minor stroke and an LVO stroke?
Minor strokes usually involve small-vessel lacunar infarcts. LVO strokes involve major arteries (ICA, MCA, Basilar), leading to significantly larger areas of damage and higher disability.

2. How soon must a patient receive treatment for an LVO?
The "Golden Hour" applies. IVT is effective within 4.5 hours, and mechanical thrombectomy is most effective within 6 hours, though it can be performed up to 24 hours post-onset if imaging shows viable penumbra.

3. What is the ASPECT score?
The Alberta Stroke Program Early CT Score is a 10-point quantitative score used on non-contrast CT scans to assess the extent of early ischemic changes. A lower score indicates a larger infarct.

4. Can a patient have an LVO with a normal CT scan?
Yes. In the very hyperacute stage (first 30–60 minutes), the NCCT may appear normal despite a large clot in the vessel. This is why CTA is required.

5. What is the "penumbra"?
The penumbra is the "at-risk" tissue surrounding the dead core. It is ischemic but not yet dead, and it is the primary target of acute stroke interventions.

6. Is mechanical thrombectomy always successful?
While highly effective, success depends on clot burden, vessel tortuosity, and time. Successful recanalization is defined by a TICI score of 2b or 3.

7. Why is blood pressure management so critical?
If the BP is too low, the penumbra dies due to hypoperfusion. If it is too high, the risk of hemorrhagic transformation increases. Strict protocols are followed during the acute phase.

8. What role does collateral circulation play?
Collaterals act as a "backup" blood supply. Patients with robust collateral circulation may have a smaller infarct core despite an LVO, extending the time window for successful treatment.

9. What are the common long-term complications?
Post-stroke depression, spasticity, dysphagia, cognitive impairment, and a high risk of recurrent stroke.

10. What is the "DAWN" criteria?
The DAWN trial demonstrated that some patients can benefit from thrombectomy up to 24 hours after onset if their clinical deficit is severe but the infarct core (on imaging) remains relatively small (mismatch).

8. Clinical Summary Table: LVO Management

Conclusion

Acute Ischemic Stroke due to Large Vessel Occlusion is a time-sensitive, potentially devastating condition that requires an organized, rapid-response system. By utilizing advanced neuroimaging and timely mechanical intervention, clinicians can significantly reduce the burden of permanent disability. The integration of clinical assessment with radiographic findings remains the cornerstone of modern stroke neurology, ensuring that the right patient receives the right treatment at the right time.

Related Clinical Integration

In the management of Acute Ischemic Stroke (Large Vessel Occlusion), a multidisciplinary approach is essential to restore cerebral perfusion and mitigate long-term neurological deficits. Pharmacological intervention begins with the administration of Alteplase / ألتيبلاز Standard for thrombolysis, followed by secondary prevention strategies including Aspirin (Enteric Coated) / أسبرين (مغلف معوياً) 81mg. For patients meeting criteria for mechanical intervention, Endovascular Mechanical Thrombectomy / استئصال الخثرة الميكانيكي داخل الأوعية الدموية (عملية كبرى في غرف العمليات) serves as the gold standard, utilizing specialized Aspiration Catheters / Stent Retrievers / قساطر الشفط / مسترجعات الدعامات (أجهزة دعم وتكبير الجراحة) navigated via a Coronary Guidewire - BMW / سلك توجيه تاجي - BMW to achieve rapid recanalization. While these acute stroke protocols focus on neurovascular restoration, clinicians should maintain a broad understanding of ischemic pathology and vascular management, as evidenced by principles discussed in Mastering Hand Revascularization: A Comprehensive Intraoperative Guide to Sympathectomy, Microvascular Reconstruction, and Embolectomy, as well as the critical diagnostic and management frameworks for ischemic tissue injury found in Management of Forearm Compartment Syndrome and Volkmann Ischemic Contracture, [Compartment Syndrome and Volkmann Contracture: Surgical Management](https://www.hutaifortho.com/en/hub/compartment-syndromes-and-volkmann-contracture-a-master-surgical